Background
==========

ODIN was a Phase IIIb, randomised, open-label trial showing non-inferiority of DRV/r 800/100mg qd vs 600/100mg bid (+ ≥2 NRTIs) in treatment-experienced HIV-1-infected adults with no DRV resistance-associated mutations at screening. We evaluated the effect of demographic and baseline (BL) disease parameters on virological response (VR) of qd vs bid DRV/r at Week 48.

Methods
=======

Week 48 VR (HIV-1 RNA \<50 copies/mL; ITT-TLOVR) was analysed by subgroups including gender, age, race, HIV clade, BL HIV-1 RNA and CD4 count.

Results
=======

Week 48 VR was 72.1% for DRV/r qd vs 70.9% for bid (95% CI = -6.1 to 8.5%). Week 48 VR by gender, age, race, HIV clade, BL CD4 count and HIV-1 RNA is reported (Table [1](#T1){ref-type="table"}).

###### 

\% patients with HIV-1 RNA \<50 copies/mL at Week 48

                                          DRV/r qd                 DRV/r bid                 
  --------------------------------------- ---------- ------------- ----------- ------------- ---------------------------------
  *Baseline factor*                       N          \% response   N           \% response   Difference in response (95% CI)
                                                                                             
  HIV-1 RNA (as stratified) (copies/mL)                                                      
                                                                                             
  ≤50,000                                 222        78.4          224         76.8          1.6 (-6.2, 9.4)
                                                                                             
  \>50,000                                72         52.8          72          52.8          0.0 (-16.4, 16.4)
                                                                                             
  *CD4 count (cells/mm^3^)*                                                                  
                                                                                             
  \<50                                    13         53.8          3           100           -46.2 (-109.6, 17.3)
                                                                                             
  50-\<100                                36         58.3          35          57.1          1.2 (-22.2, 24.6)
                                                                                             
  100-\<200                               76         77.6          77          67.5          10.1 (-4.1, 24.3)
                                                                                             
  200-\<350                               108        72.2          107         74.8          -2.5 (-14.4, 9.3)
                                                                                             
  ≥350                                    61         77.0          74          74.3          2.7 (-12.0, 17.4)
                                                                                             
  *Gender*                                                                                   
                                                                                             
  Female                                  115        69.6          98          69.4          0.2 (-12.3, 12.7)
                                                                                             
  Male                                    179        73.7          198         71.7          2.0 (-7.0, 11.1)
                                                                                             
  *Age (years)*                                                                              
                                                                                             
  ≤30                                     35         71.4          35          60.0          11.4 (-11.0, 33.9)
                                                                                             
  30-≤45                                  180        75.6          169         72.8          2.8 (-6.4, 12)
                                                                                             
  45-≤55                                  64         60.9          72          72.2          -11.3 (-27.2, 4.6)
                                                                                             
  55-≤65                                  14         78.6          18          66.7          11.9 (-20.6, 44.4)
                                                                                             
  \>65                                    1          100           2           100           0 (0, 0)
                                                                                             
  *Race*                                                                                     
                                                                                             
  Black                                   83         62.7          72          65.3          -2.6 (-17.9, 12.7)
                                                                                             
  Caucasian                               102        71.6          110         69.1          2.5 (-9.9, 14.9)
                                                                                             
  Hispanic                                47         72.3          59          67.8          4.5 (-13.2, 22.3)
                                                                                             
  Asian                                   48         89.6          41          87.8          1.8 (-11.6, 15.1)
                                                                                             
  Other                                   14         71.4          14          78.6          -7.1 (-40.7, 26.4)
                                                                                             
  *Clade*                                                                                    
                                                                                             
  B                                       179        70.4          199         64.3          6.4 (-3.4, 15.6)
                                                                                             
  Non-B                                   115        74.8          97          84.5          -9.8 (-20.7,1.2)

Conclusions
===========

VR was comparable with DRV/r qd and bid regardless of subgroup analysed. As the trial was not powered for treatment comparisons in subgroups, and as numbers were small for some subgroups, these exploratory findings should be interpreted with caution.
